VERA
Vera Therapeutics, Inc.NASDAQHealthcare$40.86+0.89%ClosedMarket Cap: $2.92B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
4.30
P/S
0.00
EV/EBITDA
-9.09
DCF Value
$4.05
FCF Yield
-8.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-59.7%
ROA
-40.8%
ROIC
-46.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | Infinity% | $-94.2M | $-91.1M | $-1.39 | — |
| FY 2025 | $0.00 | -Infinity% | $-315.5M | $-299.6M | $-4.66 | — |
| Q3 2025 | $0.00 | -Infinity% | $-83.9M | $-80.3M | $-1.26 | — |
| Q2 2025 | $0.00 | -Infinity% | $-80.1M | $-76.5M | $-1.20 | — |
| Q1 2025 | $0.00 | NaN% | $-57.2M | $-51.7M | $-0.81 | — |
| Q4 2024 | $0.00 | NaN% | $-48.9M | $-43.4M | $-0.85 | — |
| FY 2024 | $0.00 | NaN% | $-167.2M | $-152.1M | $-2.75 | — |
| Q3 2024 | $0.00 | NaN% | $-49.8M | $-46.6M | $-0.85 | — |
| Q2 2024 | $0.00 | NaN% | $-37.3M | $-33.7M | $-0.62 | — |
| Q1 2024 | $0.00 | Infinity% | $-31.1M | $-28.4M | $-0.56 | — |
| Q4 2023 | $0.00 | Infinity% | $-27.0M | $-25.7M | $-0.58 | — |
| FY 2023 | $0.00 | NaN% | $-102.0M | $-96.0M | $-2.25 | — |